DAY 2
Friday, 28 May 2026
8h15
Welcome coffee and registration
8h45
Keynote lecture
- Plenary
Chairman
8h45
From Patient to Platform and Back to the Clinic: iPSC-Derived Cardiomyocytes for Precision Disease Modeling and Drug Discovery
Massimiliano Gnecchi
Professor of Cardiology
Università di Pavia - Italy
Director, Translational Cardiology Unit
Fondazione IRCCS Policlinico San Matteo - Italy
9h15
Track 3: Gene Editing: Shaping the Future Today
- Plenary
Chairman
9h15
Title to be confirmed
Boris Greber
Managing Director
Catalent Pharma Solutions - France
9h35
Title to be confirmed
Emiliano Ricci
Researcher
ENS Lyon - France
9h55
Title to be confirmed
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
10h15
Q&A Session
10h30
Coffee break - Exhibition Hall
11h00
Roundtable: Gene therapy: technological bottlenecks or a business model challenge?
- Plenary
Animated by MabDesign
11h00
To be determined
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
12h00
Lunch - Exhibition Hall - B2B Meetings
14h00
Keynote lecture
- Plenary
Chairman
14h00
Towards clinical-scale manufacturing of cells and derived-EVs in bioreactors
Marta Costa
Principal Scientist
iBET - Portugal
14h30
Track 4: EVs and the Secretome: From Biology to Therapy
- Plenary
Chairman
14h30
From Biomanufacturing to Therapy: Scalable Production of MSC-Derived EV Secretome and Development of the EVerGel Platform
Clément Bonamy
Head of External Innovation
EverZom - France
14h50
Message in a Bubble: Utilizing Engineered Extracellular Vesicles for Targeted Drug Delivery
Andre Görgens
Researcher
Karolinska Institutet - Sweden
15h10
Title to be confirmed
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
15h30
Q&A Session
15h45
Coffee break - Exhibition Hall
16h15
Track 5: Quality and Technical Challenges in Advanced Therapies
- Plenary
Chairman
16h15
Title to be confirmed
Christine Baldeschi
Researcher
I-Stem - France
16h35
Lentiviral Production for In Vivo Delivery: Challenges & Opportunities
Guillaume Sirgue
Director Technical Excellence
Oxford Biomedica - France
16h35
Enabling Gene Therapy Development Through Clinical Supply Chain Excellence
Claire Virenque
Clinical Supply Project Leader
Sanofi - France
16h55
Speaker 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h15
Q&A Session
17h30